PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial.
Frédéric Dumont, V. Képénékian, Christophe Passot, Anne-Cécile Ezanno-Manasterski +11 more

